Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922620 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine vs Peripheral Nerve Block
A Phase 4 study, sponsored by Geisinger Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT03922620: Clinical Trial Phase 4 study, sponsored by Geisinger Clinic.
NCT03922620 is a Phase 4 study that was terminated before completion, run by Geisinger Clinic. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03922620, a Phase 4 study, was terminated before completion, sponsored by Geisinger Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.
Primary Outcome
Best 0-10 worst - Continuous scale to measure current pain level
Interventions
- DRUG Liposomal bupivacaine
- DRUG Peripheral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
Why NCT03922620 stopped before completion
NCT03922620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT03922620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03922620 about?
NCT03922620 is a clinical study titled "Liposomal Bupivacaine vs Peripheral Nerve Block". Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupiva...
What is the current status of trial NCT03922620?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2020-01-23. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03922620?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Peripheral Nerve Block (DRUG).
Who is sponsoring clinical trial NCT03922620?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03922620's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI